다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Aging, v.3 no.7, 2011년, pp.685 - 691
Blagosklonny, Mikhail V. (Department of Cell Stress Biology, Roswell Park Cancer Institute, BLSC, L3-312, Elm and Carlton Streets, Buffalo, NY, 14263, USA)
AI-Helper
A recent discovery that rapamycin suppresses a pro-senescent phenotype in progeric cells not only suggests a non-toxic therapy for progeria but also implies its similarity with normal aging. For one, rapamycin is also known to suppress aging of regular human cells. Here I discuss four potential scen...
Cao K Graziotto JJ Blair CD Mazzulli JR Erdos MR Krainc D Collins FS Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in hutchinson-gilford progeria syndrome cells Sci Transl Med 2011 3 89ra58
Demidenko ZN Zubova SG Bukreeva EI Pospelov VA Pospelova TV Blagosklonny MV Rapamycin decelerates cellular senescence Cell Cycle 2009 8 1888 1895 19471117
Capell BC Collins FS Nabel EG Mechanisms of cardiovascular disease in accelerated aging syndromes Circ Res 2007 101 13 26 17615378
Hennekam RC Hutchinson-Gilford progeria syndrome: review of the phenotype Am J Med Genet A 2006 140 2603 2624 16838330
Merideth MA Gordon LB Clauss S Sachdev V Smith AC Perry MB Brewer CC Zalewski C Kim HJ Solomon B Brooks BP Gerber LH Turner ML Domingo DL Hart TC Graf J Phenotype and course of Hutchinson-Gilford progeria syndrome N Engl J Med 2008 358 592 604 18256394
Burtner CR Kennedy BK Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol 2010 11 567 578 20651707
Eriksson M Brown WT Gordon LB Glynn MW Singer J Scott L Erdos MR Robbins CM Moses TY Berglund P Dutra A Pak E Durkin S Csoka AB Boehnke M Glover TW Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome Nature 2003 423 293 298 12714972
Ho JC Zhou T Lai WH Huang Y Chan YC Li X Wong NL Li Y Au KW Guo D Xu J Siu CW Pei D Tse HF Esteban MA Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C Aging 2011 3 380 390 21483033
Allsopp RC Vaziri H Patterson C Goldstein S Younglai EV Futcher AB Greider CW Harley CB Telomere length predicts replicative capacity of human fibroblasts Proc Natl Acad Sci U S A 1992 89 10114 10118 1438199
Cao K Blair CD Faddah DA Kieckhaefer JE Olive M Erdos MR Nabel EG Collins FS Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts J Clin Invest 2011
Benson EK Lee SW Aaronson SA Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence J Cell Sci 2010 123 2605 2612 20605919
Huang S Risques RA Martin GM Rabinovitch PS Oshima J Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A Exp Cell Res 2008 314 82 91 17870066
Kudlow BA Stanfel MN Burtner CR Johnston ED Kennedy BK Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53 Mol Biol Cell 2008 19 5238 5248 18843043
Varela I Cadinanos J Pendas AM Gutierrez-Fernandez A Folgueras AR Sanchez LM Zhou Z Rodriguez FJ Stewart CL Vega JA Tryggvason K Freije JM Lopez-Otin C Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation Nature 2005 437 564 568 16079796
Musich PR Zou Y Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A Aging 2009 1 28 37 19851476
Gonzalez-Suarez I Redwood AB Gonzalo S Loss of A-type lamins and genomic instability Cell Cycle 2009 8 3860 3865 19901537
Demidenko ZN Blagosklonny MV Growth stimulation leads to cellular senescence when the cell cycle is blocked Cell Cycle 2008 7 3355 3361 18948731
Blagosklonny MV Aging-suppressants: cellular senescence (hyperactivation) and its pharmacological deceleration Cell Cycle 2009 8 1883 7 19448395
Blagosklonny MV Cell cycle arrest is not senescence Aging 2011 3 94 101 21297220
Bodnar AG Ouellette M Frolkis M Holt SE Chiu CP Morin GB Harley CB Shay JW Lichtsteiner S Wright WE Extension of life-span by introduction of telomerase into normal human cells Science 1998 279 349 352 9454332
Wei S Sedivy JM Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts Cancer Res 1999 59 1539 1543 10197626
Beausejour CM Krtolica A Galimi F Narita M Lowe SW Yaswen P Campisi J Reversal of human cellular senescence: roles of the p53 and p16 pathways EMBO J 2003 22 4212 4222 12912919
Blagosklonny MV Cell senescence and hypermitogenic arrest EMBO Rep 2003 4 358 362 12671679
Dimri GP Campisi J Molecular and cell biology of replicative senescence Cold Spring Harb Symp Quant Biol 1994 59 67 73 7587128
Itahana K Campisi J Dimri GP Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay Methods Mol Biol 2007 371 21 31 17634571
CoppŽ JP Patil CK Rodier F Sun Y Mu-oz DP Goldstein J Nelson PS Desprez PY Campisi J Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor PLoS Biol 2008 6 2853 2868 19053174
Bhaumik D Scott GK Schokrpur S Patil CK Orjalo AV Rodier F Lithgow GJ Campisi J MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8 Aging 2009 1 402 411 20148189
Rodier F Coppe JP Patil CK Hoeijmakers WA Munoz DP Raza SR Freund A Campeau E Davalos AR Campisi J Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat Cell Biol 2009 11 973 979 19597488
CoppŽ JP Kauser K Campisi J BeausŽjour CM Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence J Biol Chem 2006 281 29568 29574 16880208
Freund A Orjalo AV Desprez PY Campisi J Inflammatory networks during cellular senescence: causes and consequences Trends Mol Med 2010 238 246 20444648
Chang BD Broude EV Dokmanovic M Zhu H Ruth A Xuan Y Kandel ES Lausch E Christov K Roninson IB A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents Cancer Res 1999 59 3761 3767 10446993
Satyanarayana A Greenberg RA Schaetzlein S Buer J Masutomi K Hahn WC Zimmermann S Martens U Manns MP Rudolph KL Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling Mol Cell Biol 2004 24 5459 5474 15169907
Kuilman T Michaloglou C Vredeveld LC Douma S van Doorn R Desmet CJ Aarden LA Mooi WJ Peeper DS Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network Cell 2008 133 1019 1031 18555778
Courtois-Cox S Genther Williams SM Reczek EE Johnson BW McGillicuddy LT Johannessen CM Hollstein PE MacCollin M Cichowski K A negative feedback signaling network underlies oncogene-induced senescence Cancer Cell 2006 10 459 472 17157787
Acosta JC O'Loghlen A Banito A Guijarro MV Augert A Raguz S Fumagalli M Da Costa M Brown C Popov N Takatsu Y Melamed J d'Adda di Fagagna F Bernard D Hernando E Gil J Chemokine signaling via the CXCR2 receptor reinforces senescence Cell 2008 133 1006 1018 18555777
Dulic V Drullinger LF Lees E Reed SI Stein GH Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes Proc Natl Acad Sci U S A 1993 90 11034 11038 8248208
Wong H Riabowol K Differential CDK-inhibitor gene expression in aging human diploid fibroblasts Exp Gerontol 1996 31 311 325 8706801
Burton DG Sheerin AN Ostler EL Smith K Giles PJ Lowe J Rhys-Williams W Kipling DG Faragher RG Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cells Ann N Y Acad Sci 2007 1119 20 31 18056951
Kurz DJ Decary S Hong Y Erusalimsky JD Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells J Cell Sci 2000 113 Pt 20 3613 3622 11017877
Lee BY Han JA Im JS Morrone A Johung K Goodwin EC Kleijer WJ DiMaio D Hwang ES Senescence-associated beta-galactosidase is lysosomal beta-galactosidase Aging Cell 2006 5 187 195 16626397
Lou Z Wei J Riethman H Baur JA Voglauer R Shay JW Wright WE Telomere length regulates ISG15 expression in human cells Aging 2009 1 608 621 20157543
Pospelova TV Demidenk ZN Bukreeva EI Pospelov VA Gudkov AV Blagosklonny MV Pseudo-DNA damage response in senescent cells Cell Cycle 2009 8 4112 4118 19946210
Chang BD Broude EV Fang J Kalinichenko TV Abdryashitov R Poole JC Roninson IB p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells Oncogene 2000 19 2165 2170 10815808
Gan B DePinho RA mTORC1 signaling governs hematopoietic stem cell quiescence Cell Cycle 2009 8 1003 1006 19270523
Chen C Liu Y Liu R Ikenoue T Guan KL Zheng P TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species J Exp Med 2008 205 2397 2408 18809716
Chen C Liu Y Zheng P mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells Sci Signal 2009 2 ra75 19934433
Sherr CJ DePinho RA Cellular senescence: mitotic clock or culture shock? Cell 2000 102 407 410 10966103
Serrano M Blasco MA Putting the stress on senescence Curr Opin Cell Biol 2001 13 748 53 11698192
Itahana K Dimri G Campisi J Regulation of cellular senescence by p53 Eur J Biochem 2001 268 2784 2791 11358493
Collado M Blasco MA Serrano M Cellular senescence in cancer and aging Cell 2007 130 223 233 17662938
Demidenko ZN Shtutman M Blagosklonny MV Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence Cell Cycle 2009 8 1896 1900 19478560
Demidenko ZN Blagosklonny MV At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence Cell Cycle 2009 8 1901 1904 19471118
Demidenko ZN Blagosklonny MV Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential Aging 2009 1 1008 1016 20157583
Demidenko ZN Korotchkina LG Gudkov AV Blagosklonny MV Paradoxical suppression of cellular senescence by p53 Proc Natl Acad Sci U S A 2010 9660-4 9660 9664 20457898
Leontieva OV Blagosklonny MV DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence Aging 2010 2 924 935 21212465
Feng Z Zhang H Levine AJ Jin S The coordinate regulation of the p53 and mTOR pathways in cells Proc Natl Acad Sci U S A 2005 102 8204 8209 15928081
Feng Z Levine AJ The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein Trends Cell Biol 2010 20 427 434 20399660
Chao SK Horwitz SB McDaid HM Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence Oncotarget 2010 2 89 98 21399233
Budanov AV Karin M p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling Cell 2008 134 451 460 18692468
Lee JH Bodmer R Bier E Karin M Sestrins at the crossroad between stress and aging Aging 2010 2 369 374 20606249
Leontieva OV Gudkov AV Blagosklonny MV Weak p53 permits senescence during cell cycle arrest Cell Cycle 2010 9 4323 4327 21051933
Korotchkina LG Leontieva OV Bukreeva EI Demidenko ZN Gudkov AV Blagosklonny MV The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway Aging 2010 2 344 352 20606252
Serrano M Shifting senescence into quiescence by turning up p53 Cell Cycle 2010 9 4256 4257 20980826
Galluzzi L Kepp O Kroemer G TP53 and MTOR crosstalk to regulate cellular senescence Aging 2010 2 535 537 20876940
Santoro R Blandino G p53: The pivot between cell cycle arrest and senescence Cell Cycle 2010 9 4262 4263 21057199
Long JS Ryan KM p53 and senescence: a little goes a long way Cell Cycle 2010 9 4050 4051
de Keizer PL Laberge RM Campisi J p53: Pro-aging or pro-longevity? Aging 2010 2 377 379 20657035
Vigneron A Vousden KH p53, ROS and senescence in the control of aging Aging 2010 2 471 474 20729567
Poyurovsky MV Prives C P53 and aging: A fresh look at an old paradigm Aging 2010 2 380 382 20657036
Lane DP Verma C Fang CC The p53 inducing drug dosage may determine quiescence or senescence Aging 2010 2 748 21068468
Schmelzle T Hall MN TOR, a central controller of cell growth Cell 2000 103 253 262 11057898
Edinger AL Thompson CB Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake Mol Biol Cell 2002 13 2276 2288 12134068
Sarbassov DD Ali SM Sabatini DM Growing roles for the mTOR pathway Curr Opin Cell Biol 2005 17 596 603 16226444
Blagosklonny MV Hall MN Growth and Aging: a common molecular mechanism Aging 2009 1 357 362 20157523
Zhang H Cicchetti G Onda H Koon HB Asrican K Bajraszewski N Vazquez F Carpenter CL Kwiatkowski DJ Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR J Clin Invest 2003 112 1223 1233 14561707
Tremblay F Marette A Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells J Biol Chem 2001 276 38052 38060 11498541
Manning BD Logsdon MN Lipovsky A Abbott D Kwiatkowski DJ Cantley LC Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2 Genes Dev 2005 19 1773 1778 16027169
Harrington LS Findlay GM Lamb RF Restraining PI3K: mTOR signalling goes back to the membrane Trends Biochem Sci 2005 30 35 42 15653324
Mordier S Iynedjian PB Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes Biochem Biophys Res Commun 2007 362 206 211 17698034
Pani G P66SHC and ageing: ROS and TOR? Aging 2010 2 514 518 20689155
Hsu PP Kang SA Rameseder J Zhang Y Ottina KA Lim D Peterson TR Choi Y Gray NS Yaffe MB Marto JA Sabatini DM The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling Science 2011 332 1317 1322 21659604
Yu Y Yoon SO Poulogiannis G Yang Q Ma XM Villen J Kubica N Hoffman GR Cantley LC Gygi SP Blenis J Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling Science 2011 332 1322 1326 21659605
Blagosklonny MV Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition Cell Cycle 2006 5 2087 2102 17012837
Blagosklonny MV Prevention of cancer by inhibiting aging Cancer Biol Ther 2008 7 1520 1524 18769112
Blagosklonny MV Validation of anti-aging drugs by treating age-related diseases Aging 2009 1 281 288 20157517
Tsang CK Qi H Liu LF Zheng XFS Targeting mammalian target of rapamycin (mTOR) for health and diseases Drug Disc Today 2007 12 112 124
Vellai T Takacs-Vellai K Zhang Y Kovacs AL Orosz L Muller F Genetics: influence of TOR kinase on lifespan in C. elegans Nature 2003 426 620 14668850
Kapahi P Zid BM Harper T Koslover D Sapin V Benzer S Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway Curr Biol 2004 14 885 890 15186745
Powers RWr Kaeberlein M Caldwell SD Kennedy BK Fields S Extension of chronological life span in yeast by decreased TOR pathway signaling Genes Dev 2006 20 174 184 16418483
Pan KZ Palter JE Rogers AN Olsen A Chen D Lithgow GJ Kapahi P Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans Aging Cell 2007 6 111 119 17266680
Pan Y Shadel GS Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density Aging 2009 1 131 145 20157595
Selman C Tullet JM Wieser D Irvine E Lingard SJ Choudhury AI Claret M Al-Qassab H Carmignac D Ramadani F Woods A Robinson IC Schuster E. Batterham R.L. Kozma S.C. Thomas G. Carling D. Okkenhaug K. Thornton J.M. Partridge L. Gems D. Withers D.J. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span Science 2009 326 140 144 19797661
Zid BM Rogers AN Katewa SD Vargas MA Kolipinski MC Lu TA Benzer S Kapahi P 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila Cell 2009 139 149 160 19804760
Moskalev AA Shaposhnikov MV Pharmacological Inhibition of Phosphoinositide 3 and TOR Kinases Improves Survival of Drosophila melanogaster Rejuvenation Res 2009 13 246 7 20017609
Bjedov I Toivonen JM Kerr F Slack C Jacobson J Foley A Partridge L Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster Cell Metab 11 35 46 20074526
Harrison DE Strong R Sharp ZD Nelson JF Astle CM Flurkey K Nadon NL Wilkinson JE Frenkel K Carter CS Pahor M Javors MA Fernandezr E Miller RA Rapamycin fed late in life extends lifespan in genetically heterogenous mice Nature 2009 460 392 396 19587680
Anisimov VN Zabezhinski MA Popovich IG Piskunova TS Semenchenko AV Tyndyk ML Yurova MN Antoch MP Blagosklonny MV Am J Pathol 2010 176 2092 2097 20363920
McClintock D Ratner D Lokuge M Owens DM Gordon LB Collins FS Djabali K The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin PLoS One 2007 2 e1269 18060063
Gadalla SM Cawthon R Giri N Alter BP Savage SA Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes Aging 2010 2 867 874 21113082
Hetzer MW The role of the nuclear pore complex in aging of post-mitotic cells Aging 2010 2 74 75 20354266
Manju K Muralikrishna B Parnaik VK Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci J Cell Sci 2006 119 2704 2714 16772334
Brenneisen P Wenk J Wlaschek M Krieg T Scharffetter-Kochanek K Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts J Biol Chem 2000 275 4336 4344 10660603
Pospelova TV Demidenko ZN Bukreeva EI Pospelov VA Gudkov AV Blagosklonny MV Pseudo-DNA damage response in senescent cells Cell Cycle 2009 8 4112 4118 19946210
Rodriguez-Jimenez FJ Moreno-Manzano V Mateos-Gregorio P Royo I Erceg S Murguia JR Sanchez-Puelles JM FM19G11: A new modulator of HIF that links mTOR activation with the DNA damage checkpoint pathways Cell Cycle 2010 9 2803 2813 20676050
Alexander A Walker CL Differential localization of ATM is correlated with activation of distinct downstream signaling pathways Cell Cycle 2010 9 3685 3686 20890104
Cavallini G Donati A Taddei M Bergamini E Evidence for Selective Mitochondrial Autophagy and Failure in Aging Autophagy 2007 3 1
Hands SL Proud CG Wyttenbach A mTOR's role in ageing: protein synthesis or autophagy? Aging 2009 1 586 597 20157541
Morselli E Galluzzi L Kepp O Criollo A Maiuri MC Tavernarakis N Madeo F Kroemer G Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol Aging 2009 1 961 970 20157579
Ravikumar B Vacher C Berger Z Davies JE Luo S Oroz LG Scaravilli F Easton DF Duden R O'Kane CJ Rubinsztein DC Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease Nat Genet 2004 36 585 595 15146184
Berger Z Ravikumar B Menzies FM Oroz LG Underwood BR Pangalos MN Schmitt I Wullner U Evert BO O'Kane CJ Rubinsztein DC Rapamycin alleviates toxicity of different aggregate-prone proteins Hum Mol Genet 2006 15 433 442 16368705
Fontaine KR Redden DT Wang C Westfall AO Allison DB Years of life lost due to obesity Jama 2003 289 187 193 12517229
Blagosklonny MV Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program Cell Cycle 2010 9 3151 3156 20724817
Blagosklonny MV mTOR-driven aging: speeding car without brakes Cell Cycle 2009 8 4055 4059 19923900
Blagosklonny MV Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans) Cell Cycle 2010 9 683 688 20139716
Blagosklonny MV Rapamycin and quasi-programmed aging: Four years later Cell Cycle 2010 9 1859 1862 20436272
Capell BC Erdos MR Madigan JP Fiordalisi JJ Varga R Conneely KN Gordon LB Der CJ Cox AD Collins FS Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome Proc Natl Acad Sci U S A 2005 102 12879 12884 16129833
Yang SH Bergo MO Toth JI Qiao X Hu Y Sandoval S Meta M Bendale P Gelb MH Young SG Fong LG Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation Proc Natl Acad Sci U S A 2005 102 10291 10296 16014412
Scaffidi P Misteli T Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome Nat Med 2005 11 440 445 15750600
Mallampalli MP Huyer G Bendale P Gelb MH Michaelis S Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome Proc Natl Acad Sci U S A 2005 102 14416 14421 16186497
Fong LG Frost D Meta M Qiao X Yang SH Coffinier C Young SG A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria Science 2006 311 1621 1623 16484451
Glynn MW Glover TW Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition Hum Mol Genet 2005 14 2959 2969 16126733
Yang SH Meta M Qiao X Frost D Bauch J Coffinier C Majumdar S Bergo MO Young SG Fong LG A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation J Clin Invest 2006 116 2115 2121 16862216
Ravoet C Mineur P Robin V Debusscher L Bosly A Andre M El Housni H Soree A Bron D Martiat P Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study Ann Hematol 2008 87 881 885 18641985
Ugalde AP Marino G Lopez-Otin C Rejuvenating somatotropic signaling: a therapeutical opportunity for premature aging? Aging 2010 2 1017 1022 21212467
Mueller MA Beutner F Teupser D Ceglarek U Thiery J Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia Atherosclerosis 2008 198 39 48 17980369
Zhao L Ding T Cyrus T Cheng Y Tian H Ma M Falotico R Pratico D Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor Br J Pharmacol 2009 156 774 785 19220291
Rodriguez AE Granada JF Rodriguez-Alemparte M Vigo CF Delgado J Fernandez-Pereira C Pocovi A Rodriguez-Granillo AM Schulz D Raizner AE Palacios I O'neill W Kaluza GL Stone G Investigators OI Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis The Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study J Am Coll Cardiol 2006 47 1522 1529 16630986
Granville CA Warfel N Tsurutani J Hollander MC Robertson M Fox SD Veenstra TD Issaq HJ Linnoila RI Dennis PA Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors Clin Cancer Res 2007 13 2281 2289 17404113
Anisimov VN Zabezhinski MA Popovich IG Piskunova TS Semenchenko AV Tyndyk ML Yurova MN Antoch MP Blagosklonny MV Rapamycin extends maximal lifespan in cancer-prone mice Am J Pathol 2010 176 2092 2097 20363920
Mathew T Kreis H Friend P Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies Clin Transplant 2004 18 446 449 15233824
Kauffman HM Cherikh WS Cheng Y Hanto DW Kahan BD Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies Transplantation 2005 80 883 889 16249734
Blagosklonny MV Prevention of cancer by inhibiting aging Cancer Biol Ther 2008 7 1520 1524 18769112
Araki K Turner AP Shaffer VO Gangappa S Keller SA Bachmann MF Larsen CP Ahmed R mTOR regulates memory CD8 T-cell differentiation Nature 2009 460 108 112 19543266
Rao RR Li Q Shrikant PA Fine-tuning CD8(+) T cell functional responses: mTOR acts as a rheostat for regulating CD8(+) T cell proliferation, survival and differentiation? Cell Cycle 2010 9 2996 3001 20699660
Blagosklonny MV An anti-aging drug today: from senescence-promoting genes to anti-aging pill Drug Disc Today 2007 12 218 224
Major P Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex Aging 2011 3 189 191 21415462
Blagosklonny MV Increasing healthy lifespan by suppressing aging in our lifetime: Preliminary proposal Cell Cycle 2010 2 4788 4794 21150328
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.